title: Aspirin as adjuvant therapy for stage III colon cancer: standard of care?
authors.affiliation: Department of Medicine and Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeon, and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.
authors.forename: Alfred I
authors.initials: AI
authors.lastname: Neugut
mesh_terms: D001241:Aspirin / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis*; D058534:Class I Phosphatidylinositol 3-Kinases; D003110:Colonic Neoplasms / Q000188:drug therapy*; D051546:Cyclooxygenase 2 / Q000032:analysis*; D005260:Female; D015395:Histocompatibility Antigens Class I / Q000032:analysis*; D006801:Humans; D008297:Male; D019869:Phosphatidylinositol 3-Kinases / Q000032:analysis*
chemical_list: D014408:Biomarkers, Tumor; D015395:Histocompatibility Antigens Class I; D051546:Cyclooxygenase 2; D019869:Phosphatidylinositol 3-Kinases; D058534:Class I Phosphatidylinositol 3-Kinases; C484760:PIK3CA protein, human; D001241:Aspirin